Skip to main content
Premium Trial:

Request an Annual Quote

Inova to Use GenoSpace Platform for Whole-Genome Sequencing Project

NEW YORK (GenomeWeb) –Inova Health System, a not-for-profit healthcare system in Washington, DC, will use GenoSpace's Population Analytics platform to analyze and explore clinical and genomic data from an ongoing whole-genome sequencing initiative, GenoSpace said today.

Greg Eley, chief technology officer of the Inova Translational Medicine Institute, a division of the larger Inova system, said in a statement that Inova selected GenoSpace's product because of its analytical capabilities and the company's experience serving customers in R&D and clinical care.

To date, the ITMI has sequenced more than 8,000 genomes from individuals representing more than 100 countries and expects to have sequenced roughly 20,000 genomes by the end of 2015. These sequences have been linked to extensive clinical data with the goal of discovering genetic factors contributing to a wide range of diseases.

"We needed an effective solution to the challenge of making petabytes of genomic data accessible to the scientists and physicians in our organization," Eley said.  GenoSpace's platform provides the tools needed by Inova staff "to efficiently gain insight from large quantities of complex information."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.